Delivery Order SPE2DB22D3016-SPE2DB25FBGM9
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, for the supply of epinephrine 0.3 mg auto-injector auto-inject 2-packs under a firm fixed-price contract. The contract ceiling value is $3,545.04, with an ultimate completion date of September 11, 2025. This non-set-aside, competitively awarded delivery order was issued by the Defense Logistics Agency to support federal medical procurement...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency valued at $4,379.18 for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract is classified as a non-set-aside, competitively awarded delivery order with firm fixed pricing and an ultimate completion date of September 17, 2025. This award represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 27, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-packs) with a ceiling value of $1,455.73. This is a firm fixed-price, non-set-aside contract awarded by the Defense Logistics Agency's Medical Supply Chain division, with an ultimate completion date of August 28, 2025. The place of performance is the vendor's corporate office in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $5,465.70 by the Defense Logistics Agency (DLA) for the supply of Epinephrine 0.3 mg auto-injector packs (quantity 2) with an ultimate completion date of July 18, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded competitively on July 17, 2025. The award will be fulfilled at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,772.52 on August 21, 2025, by the Defense Logistics Agency (DLA) for the supply of epinephrine 0.3 mg auto-injector two-packs. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 22, 2025. The contract will be performed at the company's Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a $1,082.90 firm fixed price delivery order on August 1, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with an ultimate completion date of August 4, 2025. The contract is unclassified with no set-aside designation and represents a competitively awarded delivery against AmerisourceBergen's existing Indefinite Delivery Contract with the Defense Logistics Agency (DLA). Performance will be executed from the contractor's facility in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,989.96 by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Epinephrine 0.3 mg auto-injector pens (2-pack). The order, with an ultimate completion date of September 22, 2025, carries firm fixed pricing with no set-aside designation, indicating it was awarded through open competition. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 8, 2025, valued at $4,324.23 by the Defense Logistics Agency for the supply of Epinephrine 0.3 mg auto-injector (two-pack units). The contract represents a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting the contractor's capability...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $2,859.06 by the Defense Logistics Agency on August 4, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack). The award represents a child contract issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBGM9Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $10,644.78 delivery order by the Defense Logistics Agency on August 28, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs. The contract utilizes firm fixed pricing and carries an ultimate completion date of August 29, 2025, with performance taking place at the company's Conshohocken facility. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. No set-aside designation was applied to this award. The auto-injector delivery represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply chain. The company's SPE2DX umbrella contract serves as a comprehensive global pharmaceutical support vehicle enabling the supply of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and other government healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The competitive, non-set-aside nature of AmerisourceBergen's federal awards demonstrates the company's established capability to meet federal procurement standards for emergency medical supplies and pharmaceutical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 8/28/25 |